These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 14585694)
41. Electrospun polycaprolactone/chitosan scaffolds for nerve tissue engineering: physicochemical characterization and Schwann cell biocompatibility. Bolaina-Lorenzo E; Martínez-Ramos C; Monleón-Pradas M; Herrera-Kao W; Cauich-Rodríguez JV; Cervantes-Uc JM Biomed Mater; 2016 Dec; 12(1):015008. PubMed ID: 27934786 [TBL] [Abstract][Full Text] [Related]
42. Processing of polycaprolactone and polycaprolactone-based copolymers into 3D scaffolds, and their cellular responses. Hoque ME; San WY; Wei F; Li S; Huang MH; Vert M; Hutmacher DW Tissue Eng Part A; 2009 Oct; 15(10):3013-24. PubMed ID: 19331580 [TBL] [Abstract][Full Text] [Related]
43. In vitro biocompatibility of different polyester membranes. Vaquette C; Fawzi-Grancher S; Lavalle P; Frochot C; Viriot ML; Muller S; Wang X Biomed Mater Eng; 2006; 16(4 Suppl):S131-6. PubMed ID: 16823104 [TBL] [Abstract][Full Text] [Related]
44. Fibrous biodegradable l-alanine-based scaffolds for vascular tissue engineering. Srinath D; Lin S; Knight DK; Rizkalla AS; Mequanint K J Tissue Eng Regen Med; 2014 Jul; 8(7):578-88. PubMed ID: 22899439 [TBL] [Abstract][Full Text] [Related]
45. Electrospun bioactive nanocomposite scaffolds of polycaprolactone and nanohydroxyapatite for bone tissue engineering. Thomas V; Jagani S; Johnson K; Jose MV; Dean DR; Vohra YK; Nyairo E J Nanosci Nanotechnol; 2006 Feb; 6(2):487-93. PubMed ID: 16573049 [TBL] [Abstract][Full Text] [Related]
46. Additive manufacturing of poly[(R)-3-hydroxybutyrate-co-(R)-3-hydroxyhexanoate] scaffolds for engineered bone development. Mota C; Wang SY; Puppi D; Gazzarri M; Migone C; Chiellini F; Chen GQ; Chiellini E J Tissue Eng Regen Med; 2017 Jan; 11(1):175-186. PubMed ID: 24889107 [TBL] [Abstract][Full Text] [Related]
47. The physical properties and response of osteoblasts to solution cast films of PLGA doped polycaprolactone. Tang ZG; Callaghan JT; Hunt JA Biomaterials; 2005 Nov; 26(33):6618-24. PubMed ID: 15935466 [TBL] [Abstract][Full Text] [Related]
48. Composite PLA scaffolds reinforced with PDO fibers for tissue engineering. Cont L; Grant D; Scotchford C; Todea M; Popa C J Biomater Appl; 2013 Feb; 27(6):707-16. PubMed ID: 22071352 [TBL] [Abstract][Full Text] [Related]
49. In vitro characterization of polycaprolactone matrices generated in aqueous media. Pok SW; Wallace KN; Madihally SV Acta Biomater; 2010 Mar; 6(3):1061-8. PubMed ID: 19664731 [TBL] [Abstract][Full Text] [Related]
51. Impact of setup orientation on blend electrospinning of poly-ε-caprolactone-gelatin scaffolds for vascular tissue engineering. Suresh S; Gryshkov O; Glasmacher B Int J Artif Organs; 2018 Nov; 41(11):801-810. PubMed ID: 30376770 [TBL] [Abstract][Full Text] [Related]
52. Fibrous polymeric composites based on alginate fibres and fibres made of poly-ε-caprolactone and dibutyryl chitin for use in regenerative medicine. Boguń M; Krucińska I; Kommisarczyk A; Mikołajczyk T; Błażewicz M; Stodolak-Zych E; Menaszek E; Ścisłowska-Czarnecka A Molecules; 2013 Mar; 18(3):3118-36. PubMed ID: 23528995 [TBL] [Abstract][Full Text] [Related]
53. The development of a serum-free derived bioengineered conjunctival epithelial equivalent using an ultrathin poly(epsilon-caprolactone) membrane substrate. Ang LP; Cheng ZY; Beuerman RW; Teoh SH; Zhu X; Tan DT Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):105-12. PubMed ID: 16384951 [TBL] [Abstract][Full Text] [Related]
55. Studies of P(L/D)LA 96/4 non-woven scaffolds and fibres; properties, wettability and cell spreading before and after intrusive treatment methods. Ellä V; Gomes ME; Reis RL; Törmälä P; Kellomäki M J Mater Sci Mater Med; 2007 Jun; 18(6):1253-61. PubMed ID: 17277973 [TBL] [Abstract][Full Text] [Related]
56. Hydroxyapatite formation on sol-gel derived poly(ε-caprolactone)/bioactive glass hybrid biomaterials. Allo BA; Rizkalla AS; Mequanint K ACS Appl Mater Interfaces; 2012 Jun; 4(6):3148-56. PubMed ID: 22625179 [TBL] [Abstract][Full Text] [Related]
57. Using the Taguchi method to obtain more finesse to the biodegradable fibers. Ellä V; Rajala A; Tukiainen M; Kellomäki M Methods Mol Biol; 2012; 868():143-54. PubMed ID: 22692610 [TBL] [Abstract][Full Text] [Related]
59. Fabrication of a nanofibrous scaffold with improved bioactivity for culture of human dermal fibroblasts for skin regeneration. Chandrasekaran AR; Venugopal J; Sundarrajan S; Ramakrishna S Biomed Mater; 2011 Feb; 6(1):015001. PubMed ID: 21205999 [TBL] [Abstract][Full Text] [Related]